Will U, Füldner F, Reichel A, Meyer F
Klinik für Innere Medizin III (Gastroenterologie, Hepatologie & Allg. Innere Medizin), SRH Waldklinikum, Gera, Deutschland.
Klinik für Allgemein-, Viszeral- & Gefäßchirurgie, Universitätsklinikum Magdeburg A. ö. R., Magdeburg, Deutschland.
Zentralbl Chir. 2014 Jun;139(3):318-25. doi: 10.1055/s-0033-1350868. Epub 2013 Nov 29.
Transpapillary ERP is the gold standard in symptomatic retention of the pancreatic duct or pancreatic fistula; however, it fails in 5-10 % due to a papilla which cannot be reached or cannulated, or in postoperative changes which do not allow conventional endoscopic drainage.
Based on our clinical, endoscopic and EUS-related experience as well as a literature search, EUS-guided pancreaticography and drainage of the pancreatic duct (EUPD) are described as alternative approach i) to symptomatic retention of pancreatic duct, ii) for cases with stenoses of the pancreatic duct and anastomoses which cannot be treated with conventional endoscopy, and iii) for patients with postoperative pancreatic fistula within the diagnostic and therapeutic management, including adequate indication, performance and outcome.
EUPD is indicated in cases with i) altered anatomy of upper GI tract (congenital; papilla or pancreaticoenteric anastomosis), ii) symptomatic retention of pancreatic duct due to changes in peripapillary region or iii) stenosis of pancreatic duct/anastomosis, and iv) if surgical intervention cannot be done with a reasonable risk-benefit ratio. EUPD can provide a success rate of 25 to 92 %, a complication rate of 14 to 40 % (bleeding, perforation, pancreatitis, pain) and long-term clinical success rate of 69 to 78 % (pain-, symptom-free). Advantages are sustained endoscopic methodological variability, minimal invasiveness, improvement in quality of life, possible endoscopic revision of complications and conventional endoscopic equipment. In contrast disadvantages include high level of expertise, only low case load, long learning curve, instruments needing further optimisation, and a still not good clinical success rate of 70 % as well as status as an experimental clinical method.
With adequate experience EUPD is for carefully selected patients an uncomplicated, elegant and safe method and represents an alternative therapeutic option for the interventional endoscopist allowing more invasive procedures to be avoided. Further prospective and systematic evaluations and technical refinements of EUPD-associated results are needed in order to establish general therapeutic guidelines on indications, peri-interventional management and to define a practical guideline-relevant procedure.
经乳头内镜逆行胰胆管造影术(ERCP)是治疗胰管症状性潴留或胰瘘的金标准;然而,由于乳头无法到达或插管失败,或存在不允许进行传统内镜引流的术后改变,该方法有5% - 10%的失败率。
基于我们的临床、内镜及超声内镜相关经验以及文献检索,将超声内镜引导下胰管造影及引流术(EUPD)描述为一种替代方法,用于:i)治疗胰管症状性潴留;ii)治疗胰管及吻合口狭窄且无法用传统内镜治疗的病例;iii)在诊断和治疗管理中用于术后胰瘘患者,包括适当的适应证、操作及结果。
EUPD适用于以下情况:i)上消化道解剖结构改变(先天性;乳头或胰肠吻合口);ii)由于乳头周围区域改变导致的胰管症状性潴留;iii)胰管/吻合口狭窄;iv)手术干预的风险效益比不合理。EUPD的成功率为25%至92%,并发症发生率为14%至40%(出血、穿孔、胰腺炎、疼痛),长期临床成功率为69%至78%(无疼痛、无症状)。优点包括内镜方法的持续可变性、微创性、生活质量改善、并发症的内镜修正可能性以及使用传统内镜设备。相比之下,缺点包括专业要求高、病例数量少、学习曲线长、器械需要进一步优化、临床成功率仍不理想(70%)以及作为一种实验性临床方法的现状。
有足够经验时,EUPD对精心挑选的患者是一种简单、优雅且安全的方法,是介入内镜医师的一种替代治疗选择,可避免更具侵入性的手术。需要对EUPD相关结果进行进一步的前瞻性和系统性评估以及技术改进,以建立关于适应证、介入围手术期管理的一般治疗指南,并定义与实际指南相关的操作。